The phosphorylation of eIF2alpha is usually considered pathological in neurodegenerative conditions52–54 and its pharmacological or genetic inhibition has been shown to protect animal models of frontotemporal dementia55 and Alzheimer's disease.54 This evidence concerns the gene EIF2S1 and Alzheimer disease.